BlackRock Institutional Trust’s GenVec, Inc. GNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$257K Sell
80,123
-2
-0% -$7 ﹤0.01% 3561
2016
Q3
$377K Hold
80,125
﹤0.01% 3541
2016
Q2
$459K Hold
80,125
﹤0.01% 3518
2016
Q1
$646K Hold
80,125
﹤0.01% 3398
2015
Q4
$1.47M Hold
80,125
﹤0.01% 3221
2015
Q3
$1.85M Hold
80,125
﹤0.01% 3145
2015
Q2
$1.64M Hold
80,125
﹤0.01% 3190
2015
Q1
$2.36M Buy
80,125
+1,653
+2% +$54.3K ﹤0.01% 3043
2014
Q4
$1.63M Buy
78,472
+513
+0.7% +$9.91K ﹤0.01% 3194
2014
Q3
$1.62M Buy
77,959
+403
+0.5% +$8.85K ﹤0.01% 3170
2014
Q2
$1.99M Buy
77,556
+3,825
+5% +$93.8K ﹤0.01% 3191
2014
Q1
$1.95M Buy
73,731
+16,663
+29% +$543K ﹤0.01% 3170
2013
Q4
$1.32M Buy
57,068
+27,206
+91% +$466K ﹤0.01% 3306
2013
Q3
$391K Hold
29,862
﹤0.01% 3562
2013
Q2
$110K Buy
+29,862
New +$252K ﹤0.01% 3727

Other funds holding GNVC

BlackRock Institutional Trust's GNVC Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its GenVec, Inc. (GNVC) stake by 0% in Q4 2016, selling an estimated $7 and leaving 80,123 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #3561.

BlackRock Institutional Trust first reported a position in GNVC in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.36M in Q1 2015. 20 funds tracked by Wall St. Rank hold GNVC as of Q4 2016.

  • BlackRock Institutional Trust held 80,123 shares of GenVec, Inc. worth $257K as of Q4 2016.
  • BlackRock Institutional Trust sold 2 GenVec, Inc. shares in Q4 2016, an estimated $7.
  • GenVec, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3561 holding.
  • BlackRock Institutional Trust first reported a position in GenVec, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's GenVec, Inc. position peaked at $2.36M in Q1 2015.
  • 20 funds tracked by Wall St. Rank held GenVec, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.